Clinical implications of monoamine oxidase inhibition.
D001921:Brain / Q000187:drug effects*; D001933:Brain Stem / Q000187:drug effects / Q000378:metabolism; D002421:Caudate Nucleus / Q000187:drug effects / Q000378:metabolism; D002746:Chlorpromazine / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D007498:Iris / Q000187:drug effects*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D009184:Mydriatics; D009638:Norepinephrine / Q000378:metabolism; D010300:Parkinson Disease / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism
D008996:Monoamine Oxidase Inhibitors; D009184:Mydriatics; D012701:Serotonin; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine